GR3006207T3 - - Google Patents
Info
- Publication number
- GR3006207T3 GR3006207T3 GR920401328T GR920401328T GR3006207T3 GR 3006207 T3 GR3006207 T3 GR 3006207T3 GR 920401328 T GR920401328 T GR 920401328T GR 920401328 T GR920401328 T GR 920401328T GR 3006207 T3 GR3006207 T3 GR 3006207T3
- Authority
- GR
- Greece
- Prior art keywords
- effective
- affections
- nr5r6
- affection
- leukotriene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/84—Naphthothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Paper (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15098787 | 1987-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3006207T3 true GR3006207T3 (el) | 1993-06-21 |
Family
ID=15508808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920401328T GR3006207T3 (el) | 1987-06-17 | 1992-11-12 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4929623A (el) |
| EP (1) | EP0295656B1 (el) |
| JP (1) | JP2793195B2 (el) |
| KR (1) | KR910005709B1 (el) |
| CN (1) | CN1030757A (el) |
| AT (1) | ATE82276T1 (el) |
| AU (1) | AU610186B2 (el) |
| CA (1) | CA1322369C (el) |
| DD (1) | DD282686A5 (el) |
| DE (1) | DE3875809T2 (el) |
| DK (1) | DK328888A (el) |
| ES (1) | ES2045017T3 (el) |
| FI (1) | FI91859C (el) |
| GR (1) | GR3006207T3 (el) |
| HU (1) | HU205347B (el) |
| NO (1) | NO170929C (el) |
| NZ (1) | NZ224946A (el) |
| PH (1) | PH26553A (el) |
| PT (1) | PT87747B (el) |
| SU (1) | SU1731051A3 (el) |
| ZA (1) | ZA884277B (el) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68903484T2 (de) * | 1988-12-15 | 1993-03-18 | Rhone Poulenc Sante | 2-imino-6-polyfluoralkoxy-benzothiazol-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten. |
| IL97249A (en) * | 1990-02-23 | 1995-01-24 | Takeda Chemical Industries Ltd | Compounds of 7,6,5,4-tetrahydrothiazole] B-5,4 [pyridine and compounds of 5,6-dihydro-H4-pyrrolo] D-3,2 [thiazole, their manufacture, and pharmaceutical compositions including or |
| IE920921A1 (en) * | 1991-04-04 | 1992-10-07 | Eisai Co Ltd | Benzothiazole derivative |
| US5296486A (en) * | 1991-09-24 | 1994-03-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Leukotriene biosynthesis inhibitors |
| US5350760A (en) * | 1993-08-04 | 1994-09-27 | Merck Frosst Canada, Inc. | Aza-5,5-fused hetrocyclic acids as leukotriene antagonists |
| EP0912549A4 (en) * | 1996-06-20 | 2002-01-02 | Univ Texas | CONNECTIONS AND METHOD FOR PROVIDING ACTIVE PREPARATIONS AND THE USE THEREOF |
| WO1999025372A1 (en) | 1997-11-13 | 1999-05-27 | Histatek, Llc | Small peptides and methods for treatment of asthma and inflammation |
| GB9815696D0 (en) * | 1998-07-20 | 1998-09-16 | Pfizer Ltd | Heterocyclics |
| US6686357B1 (en) | 1999-07-15 | 2004-02-03 | Pfizer, Inc. | FKBP inhibitors |
| AU3487500A (en) * | 1999-02-08 | 2000-08-25 | Lion Bioscience Ag | Thiazole derivatives and combinatorial libraries thereof |
| ATE296814T1 (de) * | 1999-05-12 | 2005-06-15 | Neurosearch As | Ionenkanal modulierende mittel |
| TWI284639B (en) * | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
| CA2408156A1 (en) * | 2000-05-05 | 2001-11-15 | Millennium Pharmaceuticals, Inc. | Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors |
| US6750238B1 (en) * | 2000-05-12 | 2004-06-15 | The University Of Toledo | Aralkyl ester soft drugs |
| US7049326B2 (en) * | 2000-05-12 | 2006-05-23 | The University Of Toledo | Method and compositions for temporarily incapacitating subjects |
| US6756047B2 (en) * | 2000-05-12 | 2004-06-29 | The University Of Toledo | Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| YU96502A (sh) | 2000-06-21 | 2006-01-16 | F. Hoffmann-La Roche Ag. | Derivati benzotiazola |
| US6620811B2 (en) * | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| US6624163B2 (en) | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
| US7338956B2 (en) * | 2002-08-07 | 2008-03-04 | Sanofi-Aventis Deutschland Gmbh | Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| US7087761B2 (en) | 2003-01-07 | 2006-08-08 | Hoffmann-La Roche Inc. | Cyclization process for substituted benzothiazole derivatives |
| US20050118291A1 (en) * | 2003-09-10 | 2005-06-02 | Mian-Ying Wang | Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane |
| CA2535511C (en) | 2003-08-12 | 2009-11-17 | Shionogi And Co., Ltd. | Compounds having thrombopoietin receptor agonism |
| WO2005116026A1 (en) | 2004-05-24 | 2005-12-08 | F. Hoffmann-La Roche Ag | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| RU2371438C2 (ru) * | 2004-08-05 | 2009-10-27 | Ф.Хоффманн-Ля Рош Аг | Замещенные 2-ацил-2-аминотиазолы |
| DE602005008095D1 (de) | 2004-11-05 | 2008-08-21 | Hoffmann La Roche | Verfahren zur herstellung von isonikotinsäurederivaten |
| WO2006099972A1 (en) | 2005-03-23 | 2006-09-28 | F. Hoffmann-La Roche Ag | Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| ES2340321T3 (es) | 2005-09-27 | 2010-06-01 | F.Hoffmann-La Roche Ag | Oxadiazolilpirazolo-pirimidinas, como antagonistas de mglur2. |
| AU2007229492B2 (en) | 2006-03-28 | 2011-11-03 | High Point Pharmaceuticals, Llc | Benzothiazoles having histamine H3 receptor activity |
| CL2009000877A1 (es) * | 2008-04-11 | 2009-11-27 | Janssen Pharmaceutica Nv | Compuestos derivados de [tiazolopiridin o tiazolopirazin-2-iloxi fenilamina; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de un trastorno o afeccion mediado por leucotrieno a4 hidrolasa, tales como alergia, asma, inflamacion, psoriasis, lupus, miastenia gravis, entre otros. |
| UY32138A (es) | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables |
| UY32470A (es) | 2009-03-05 | 2010-10-29 | Boehringer Ingelheim Int | Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones |
| WO2010106016A1 (en) * | 2009-03-17 | 2010-09-23 | Glaxo Group Limited | Pyrimidine derivatives used as itk inhibitors |
| US8759537B2 (en) | 2010-08-20 | 2014-06-24 | Boehringer Ingelheim International Gmbh | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents |
| US8586604B2 (en) | 2010-08-20 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
| US8466186B2 (en) | 2010-12-10 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Compounds |
| US8486968B2 (en) | 2010-12-10 | 2013-07-16 | Boehringer Ingelheim International Gmbh | Compounds |
| US8674113B2 (en) | 2010-12-10 | 2014-03-18 | Boehringer Ingelheim International Gmbh | Compounds |
| CN102872012B (zh) * | 2011-11-03 | 2015-03-25 | 成都医学院 | 一种抑制蛋白激酶化合物的用途 |
| CN113959912A (zh) * | 2020-07-20 | 2022-01-21 | 深圳迈瑞生物医疗电子股份有限公司 | 抗血小板聚集干扰的白细胞检测方法、试剂及其应用 |
| CN113959911A (zh) * | 2020-07-20 | 2022-01-21 | 深圳迈瑞生物医疗电子股份有限公司 | 抗血小板聚集干扰的检测方法、试剂及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2617198A (en) * | 1945-06-13 | 1952-11-11 | Better Packages Inc | Pull-out measuring tape dispenser |
| DE927507C (de) * | 1953-02-24 | 1955-05-09 | Bayer Ag | Verfahren zur Herstellung von Derivaten des 6-Oxy-2-aminobenzthiazols |
| GB808191A (en) * | 1956-07-13 | 1959-01-28 | Robert Ronald Davies | New dyestuff intermediates |
| AR204835A1 (es) * | 1973-07-18 | 1976-03-05 | Scherico Ltd | Procedimiento para preparar benzotiazol-2-carbamatos de etilo |
| US4006242A (en) * | 1973-07-18 | 1977-02-01 | Schering Corporation | Certain benzothiazoles used in the treatment of helminthiasis |
| DK148476C (da) | 1975-04-25 | 1985-12-16 | Scherico Ltd | Analogifremgangsmaade til fremstilling af methyl-6-n-propoxybenzothiazol-2-carbamat |
| JPS5221054A (en) * | 1975-08-11 | 1977-02-17 | Teijin Ltd | Polyamide composition |
| DE2656468A1 (de) * | 1976-12-14 | 1978-06-15 | Boehringer Mannheim Gmbh | N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung |
| DE2963316D1 (en) * | 1978-01-18 | 1982-09-02 | Hoechst Ag | Process for the preparation of 2-amino-arylenothiazole compounds and their ring n-substituted derivatives |
| JPS5740492A (en) * | 1980-08-22 | 1982-03-06 | Yamanouchi Pharmaceut Co Ltd | Novel 2-phenylimidazo 2,1-b benzothiazole derivative |
| US4581457A (en) * | 1984-09-21 | 1986-04-08 | American Home Products Corporation | Heterocyclic sulfonamides |
-
1988
- 1988-06-07 FI FI882692A patent/FI91859C/fi not_active IP Right Cessation
- 1988-06-08 NZ NZ224946A patent/NZ224946A/xx unknown
- 1988-06-15 NO NO882627A patent/NO170929C/no unknown
- 1988-06-15 ES ES88109552T patent/ES2045017T3/es not_active Expired - Lifetime
- 1988-06-15 CA CA000569598A patent/CA1322369C/en not_active Expired - Fee Related
- 1988-06-15 AT AT88109552T patent/ATE82276T1/de active
- 1988-06-15 EP EP88109552A patent/EP0295656B1/en not_active Expired - Lifetime
- 1988-06-15 JP JP63147141A patent/JP2793195B2/ja not_active Expired - Lifetime
- 1988-06-15 ZA ZA884277A patent/ZA884277B/xx unknown
- 1988-06-15 DE DE8888109552T patent/DE3875809T2/de not_active Expired - Fee Related
- 1988-06-16 SU SU884356028A patent/SU1731051A3/ru active
- 1988-06-16 DD DD88316839A patent/DD282686A5/de not_active IP Right Cessation
- 1988-06-16 DK DK328888A patent/DK328888A/da not_active Application Discontinuation
- 1988-06-16 US US07/207,329 patent/US4929623A/en not_active Expired - Fee Related
- 1988-06-16 PT PT87747A patent/PT87747B/pt not_active IP Right Cessation
- 1988-06-16 HU HU883098A patent/HU205347B/hu not_active IP Right Cessation
- 1988-06-16 AU AU17699/88A patent/AU610186B2/en not_active Ceased
- 1988-06-17 KR KR1019880007320A patent/KR910005709B1/ko not_active IP Right Cessation
- 1988-06-17 CN CN88103660A patent/CN1030757A/zh active Pending
- 1988-08-08 PH PH37022A patent/PH26553A/en unknown
-
1992
- 1992-11-12 GR GR920401328T patent/GR3006207T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO882627D0 (no) | 1988-06-15 |
| DK328888D0 (da) | 1988-06-16 |
| JPS6479162A (en) | 1989-03-24 |
| ATE82276T1 (de) | 1992-11-15 |
| HUT47554A (en) | 1989-03-28 |
| AU1769988A (en) | 1988-12-22 |
| DE3875809D1 (de) | 1992-12-17 |
| SU1731051A3 (ru) | 1992-04-30 |
| EP0295656A1 (en) | 1988-12-21 |
| DE3875809T2 (de) | 1993-04-15 |
| ES2045017T3 (es) | 1994-01-16 |
| JP2793195B2 (ja) | 1998-09-03 |
| DD282686A5 (de) | 1990-09-19 |
| NO882627L (no) | 1988-12-19 |
| PT87747B (pt) | 1992-10-30 |
| NZ224946A (en) | 1990-07-26 |
| US4929623A (en) | 1990-05-29 |
| CN1030757A (zh) | 1989-02-01 |
| FI882692A (fi) | 1988-12-18 |
| FI91859C (fi) | 1994-08-25 |
| PT87747A (pt) | 1988-07-01 |
| HU205347B (en) | 1992-04-28 |
| KR890000451A (ko) | 1989-03-14 |
| NO170929B (no) | 1992-09-21 |
| CA1322369C (en) | 1993-09-21 |
| KR910005709B1 (ko) | 1991-08-02 |
| ZA884277B (en) | 1989-03-29 |
| NO170929C (no) | 1993-01-06 |
| AU610186B2 (en) | 1991-05-16 |
| DK328888A (da) | 1988-12-18 |
| EP0295656B1 (en) | 1992-11-11 |
| FI882692A0 (fi) | 1988-06-07 |
| FI91859B (fi) | 1994-05-13 |
| PH26553A (en) | 1992-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3006207T3 (el) | ||
| DE3176010D1 (en) | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same | |
| FI885594A0 (fi) | Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel. | |
| EP0268281A3 (en) | Pyrrolidineamide derivative having anti-prolyl endopeptidase activity, compositions comprising the same, processes for the preparation of the same, and the use of the same for the preparation of a medicament of therapeutic value | |
| EP0270046A3 (en) | Pharmaceutical composition for treatment of cataract | |
| IL106934A (en) | Heteroarenylpiperazines a process for their preparation and pharmaceutical compositions comprising them |